Internal Medicine, Interventional Cardiology · Orange, CA
NPI
1396776746
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1140 W. la Veta Ave., Suite # 640
Orange, CA, 92868
Phone (714) 564-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$311K
3,044 services
Medicare patients, 2024
623
Average age 77
Drug cost, 2024
$1.5M
12,215 prescriptions
Company payments, 2025
$1,649
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jairo J Marin was code 93000 (electrocardiogram), 631 times for 437 patients. In total Jairo J Marin billed 3,044 services in 62 codes, and Medicare paid $311K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 631 | 437 | $12.55 | $7,918 |
| 99214 Office E&M - Established | Office | 540 | 333 | $108.46 | $59K |
| 99213 Office E&M - Established | Office | 418 | 306 | $69.03 | $29K |
| 93306 Echocardiography (TTE/TEE) | Office | 184 | 173 | $171.95 | $32K |
| 99233 Hospital E&M - Subsequent | Facility | 141 | 52 | $105.21 | $15K |
| 93280 External Electrocardiographic Monitoring | Office | 118 | 53 | $67.64 | $7,982 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 116 | 29 | $4.96 | $576 |
| 99232 Hospital E&M - Subsequent | Facility | 81 | 39 | $70.03 | $5,673 |
| 99223 Hospital E&M - Initial | Facility | 66 | 56 | $149.29 | $9,853 |
| 99152 Anesthesia | Facility | 64 | 64 | $10.61 | $679 |
| 93325 Echocardiography (TTE/TEE) | Office | 52 | 52 | $22.94 | $1,193 |
| 93320 Echocardiography (TTE/TEE) | Office | 52 | 52 | $48.56 | $2,525 |
| 93351 Echocardiography (TTE/TEE) | Office | 52 | 52 | $209.76 | $11K |
| 93458 Percutaneous Transcatheterization | Facility | 47 | 47 | $179.56 | $8,439 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 44 | 44 | $174.65 | $7,685 |
By year: 2022 $247K for 2,722 services; 2023 $266K for 2,695 services; 2024 $311K for 3,044 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jairo J Marin prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,585 prescriptions and refills. In total Jairo J Marin wrote 12,215 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,585 | 4,483 | 494 | $16K |
| Metoprolol Succinate Generic | 917 | 2,585 | 284 | $15K |
| Amlodipine Besylate Generic | 729 | 2,030 | 227 | $4,477 |
| Metoprolol Tartrate Generic | 720 | 2,020 | 202 | $6,679 |
| Eliquis Apixaban | 662 | 1,375 | 170 | $783K |
| Losartan Potassium Generic | 643 | 1,784 | 197 | $6,675 |
| Digoxin Generic | 598 | 1,716 | 187 | $15K |
| Valsartan Generic | 590 | 1,705 | 174 | $20K |
| Furosemide Generic | 468 | 1,274 | 157 | $2,392 |
| Clopidogrel Clopidogrel Bisulfate | 356 | 991 | 113 | $4,584 |
| Carvedilol Generic | 352 | 1,013 | 104 | $3,100 |
| Hydralazine Hcl Generic | 297 | 847 | 94 | $4,427 |
| Lisinopril Generic | 266 | 780 | 93 | $2,573 |
| Sotalol Sotalol Hcl | 254 | 703 | 72 | $4,850 |
| Rosuvastatin Calcium Generic | 239 | 717 | 83 | $4,715 |
Brand drugs: 1,322 claims; generic drugs: 10,893 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jairo J Marin $1,649 ($1,649 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abiomed with $315.
| Company | Payments | Amount |
|---|---|---|
| Abiomed JNJ | 3 | $315 |
| Impulse Dynamics (USA) Inc. | 3 | $307 |
| Boston Scientific Corporation BSX | 20 | $180 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $166 |
| Shockwave Medical, Inc JNJ | 1 | $98.42 |
| InfoBionic, Inc | 1 | $81.24 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $79.78 |
| Amgen Inc. AMGN | 4 | $76.18 |
| Merck Sharp & Dohme LLC MRK | 4 | $75.63 |
| Pfizer Inc. PFE | 3 | $65.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.